Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

STX

Shield Therapeutics (STX)

Shield Therapeutics Plc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:STX
일자시간출처헤드라인심볼기업
2024/09/2515:00RNS Regulatory NewsShield Therapeutics PLC Results from Phase 3 paediatric studyLSE:STXShield Therapeutics Plc
2024/09/0419:39Alliance NewsAlliance NewsShield Therapeutics revenue triples, but cost rises widen annual lossLSE:STXShield Therapeutics Plc
2024/09/0415:00RNS Regulatory NewsShield Therapeutics PLC Interim resultsLSE:STXShield Therapeutics Plc
2024/08/2803:34Alliance NewsAlliance NewsTRADING UPDATES: Shield Therapeutics lands Canada win; RUA revenue upLSE:STXShield Therapeutics Plc
2024/08/2715:00RNS Regulatory NewsShield Therapeutics PLC ACCRUFeR® Approved by Health CanadaLSE:STXShield Therapeutics Plc
2024/08/1415:00RNS Regulatory NewsShield Therapeutics PLC Notice of interim resultsLSE:STXShield Therapeutics Plc
2024/07/2623:27Alliance NewsAlliance NewsEXECUTIVE CHANGES: Morgan Advanced Materials picks senior directorLSE:STXShield Therapeutics Plc
2024/07/2415:01RNS Regulatory NewsShield Therapeutics PLC Unaudited Q2 2024 Trading UpdateLSE:STXShield Therapeutics Plc
2024/07/2415:00RNS Regulatory NewsShield Therapeutics PLC Directorate ChangeLSE:STXShield Therapeutics Plc
2024/07/0400:26Alliance NewsAlliance NewsEARNINGS AND TRADING: ActiveOps makes profit; Contango gets investmentLSE:STXShield Therapeutics Plc
2024/07/0315:00RNS Regulatory NewsShield Therapeutics PLC $5.7m Milestone Monetization Agreement with AOPLSE:STXShield Therapeutics Plc
2024/06/2100:25RNS Regulatory NewsShield Therapeutics PLC Results of 2024 Annual General MeetingLSE:STXShield Therapeutics Plc
2024/05/2904:32Alliance NewsAlliance NewsTRADING UPDATES: NetScientific backs Wanda; Inspirit Energy wins dealLSE:STXShield Therapeutics Plc
2024/05/2815:00RNS Regulatory NewsShield Therapeutics PLC New Drug Application for Accrufer® in South KoreaLSE:STXShield Therapeutics Plc
2024/05/1023:30RNS Regulatory NewsShield Therapeutics PLC Audited results for the year ended 31 Dec 2023LSE:STXShield Therapeutics Plc
2024/05/0103:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Software Circle & Beximco report higher revenueLSE:STXShield Therapeutics Plc
2024/04/3015:00RNS Regulatory NewsShield Therapeutics PLC Business Update for Q1 2024LSE:STXShield Therapeutics Plc
2024/04/1615:00RNS Regulatory NewsShield Therapeutics PLC Notice of ResultsLSE:STXShield Therapeutics Plc
2024/02/2121:36Alliance NewsAlliance NewsShield Therapeutics sinks as strong performance marred by data issuesLSE:STXShield Therapeutics Plc
2024/02/2116:00RNS Regulatory NewsShield Therapeutics PLC Unaudited Full Year Trading UpdateLSE:STXShield Therapeutics Plc
2024/01/0920:33Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics hires former Akili leader as new CFOLSE:STXShield Therapeutics Plc
2024/01/0916:00UK RegulatoryShield Therapeutics PLC Appointment of new Chief Financial OfficerLSE:STXShield Therapeutics Plc
2023/12/0800:31Alliance NewsAlliance NewsTRADING UPDATES: Comptoir opens restaurant; Intercede wins contractLSE:STXShield Therapeutics Plc
2023/12/0716:00UK RegulatoryShield Therapeutics PLC Q3 2023 U.S. Commercial HighlightsLSE:STXShield Therapeutics Plc
2023/11/2802:24UK RegulatoryShield Therapeutics PLC PDMR Transaction NotificationLSE:STXShield Therapeutics Plc
2023/10/2019:45RNS Non-RegulatoryShield Therapeutics PLC Abstract to be presented at Healthcare ConferenceLSE:STXShield Therapeutics Plc
2023/10/1219:14Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leaveLSE:STXShield Therapeutics Plc
2023/10/1215:00UK RegulatoryShield Therapeutics PLC Chief Financial Officer TransitionLSE:STXShield Therapeutics Plc
2023/10/0401:14Alliance NewsAlliance NewsTRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium dealLSE:STXShield Therapeutics Plc
2023/10/0323:00UK RegulatoryShield Therapeutics PLC Result of REX Retail OfferLSE:STXShield Therapeutics Plc
 검색 관련기사 보기:LSE:STX